Molecular Biology of the Cell click for ASCB 2010 Annual Meeting page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBoC in Press, 10.1091/mbc.E09-06-0491 on October 7, 2009

Vol. 20, Issue 23, 4920-4931, December 1, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E09-06-0491v1
20/23/4920    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bae, G.-U.
Right arrow Articles by Krauss, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bae, G.-U.
Right arrow Articles by Krauss, R. S.

Neogenin Regulates Skeletal Myofiber Size and Focal Adhesion Kinase and Extracellular Signal-regulated Kinase Activities In Vivo and In Vitro

Gyu-Un Bae*,{dagger},{ddagger}, Youn-Joo Yang*,{dagger},{ddagger}, Guoying Jiang*, Mingi Hong*, Hye-Jin Lee{dagger}, Marc Tessier-Lavigne§, Jong-Sun Kang*,{dagger}, and Robert S. Krauss*

*Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY 10029; {dagger}Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746, South Korea; and §Division of Research, Genentech, Inc., South San Francisco, CA 94080

Submitted June 16, 2009; Revised September 8, 2009; Accepted September 28, 2009
Monitoring Editor: Richard K. Assoian

A variety of signaling pathways participate in the development of skeletal muscle, but the extracellular cues that regulate such pathways in myofiber formation are not well understood. Neogenin is a receptor for ligands of the netrin and repulsive guidance molecule (RGM) families involved in axon guidance. We reported previously that neogenin promoted myotube formation by C2C12 myoblasts in vitro and that the related protein Cdo (also Cdon) was a potential neogenin coreceptor in myoblasts. We report here that mice homozygous for a gene-trap mutation in the Neo1 locus (encoding neogenin) develop myotomes normally but have small myofibers at embryonic day 18.5 and at 3 wk of age. Similarly, cultured myoblasts derived from such animals form smaller myotubes with fewer nuclei than myoblasts from control animals. These in vivo and in vitro defects are associated with low levels of the activated forms of focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK), both known to be involved in myotube formation, and inefficient expression of certain muscle-specific proteins. Recombinant netrin-2 activates FAK and ERK in cultured myoblasts in a neogenin- and Cdo-dependent manner, whereas recombinant RGMc displays lesser ability to activate these kinases. Together, netrin-neogenin signaling is an important extracellular cue in regulation of myogenic differentiation and myofiber size.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E09-06-0491) on October 7, 2009.

{ddagger} These authors contributed equally to this work.

Address correspondence to: Robert S. Krauss (robert.krauss{at}mssm.edu) or Jong-Sun Kang (jskang{at}med.skku.ac.kr).




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
G.-U. Bae, J.-R. Lee, B.-G. Kim, J.-W. Han, Y.-E. Leem, H.-J. Lee, S.-M. Ho, M.-J. Hahn, and J.-S. Kang
Cdo Interacts with APPL1 and Activates AKT in Myoblast Differentiation
Mol. Biol. Cell, July 15, 2010; 21(14): 2399 - 2411.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2009 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.